Variant report
Variant | esv3387998 |
---|---|
Chromosome Location | chr11:71132818-71134521 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:32)
- CpG islands (count:61)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:32 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr11:71133306-71133369 | A549 | lung: | n/a | n/a |
2 | CTCF | chr11:71132797-71132890 | GM10266 | blood: | n/a | n/a |
3 | CTCF | chr11:71132814-71132883 | GM12891 | blood: | n/a | n/a |
4 | CTCF | chr11:71134357-71134386 | GM12892 | blood: | n/a | n/a |
5 | CTCF | chr11:71132760-71132910 | GM12873 | blood: | n/a | n/a |
6 | CTCF | chr11:71132820-71132879 | GM12892 | blood: | n/a | n/a |
7 | CTCF | chr11:71132801-71132851 | HepG2 | liver: | n/a | n/a |
8 | CTCF | chr11:71132810-71132861 | GM19239 | blood: | n/a | n/a |
9 | CTCF | chr11:71134180-71134330 | GM12869 | blood: | n/a | n/a |
10 | CTCF | chr11:71132790-71132907 | GM19238 | blood: | n/a | n/a |
11 | EBF1 | chr11:71134193-71134627 | GM12878 | blood: | n/a | chr11:71134421-71134432 |
12 | EBF1 | chr11:71132735-71133041 | GM12878 | blood: | n/a | chr11:71132888-71132899 |
13 | EBF1 | chr11:71134251-71134510 | GM12878 | blood: | n/a | chr11:71134421-71134432 |
14 | MAFF | chr11:71132802-71132989 | K562 | blood: | n/a | chr11:71132905-71132923 |
15 | MAFF | chr11:71132727-71133046 | HepG2 | liver: | n/a | chr11:71132905-71132923 |
16 | MAFK | chr11:71132810-71132942 | Hela-S3 | cervix: | n/a | chr11:71132906-71132921 |
17 | MAFK | chr11:71132819-71132945 | K562 | blood: | n/a | chr11:71132906-71132921 |
18 | MAFK | chr11:71132621-71133075 | HepG2 | liver: | n/a | chr11:71132906-71132921 |
19 | MAFK | chr11:71134382-71134501 | HepG2 | liver: | n/a | n/a |
20 | MAFK | chr11:71132751-71132951 | IMR90 | lung: | n/a | chr11:71132906-71132921 |
21 | MAFK | chr11:71132633-71133035 | HepG2 | liver: | n/a | chr11:71132906-71132921 |
22 | SPI1 | chr11:71132785-71133005 | GM12878 | blood: | n/a | n/a |
23 | SPI1 | chr11:71134134-71134742 | GM12878 | blood: | n/a | chr11:71134475-71134484 |
24 | SPI1 | chr11:71134386-71134531 | GM12878 | blood: | n/a | chr11:71134475-71134484 |
25 | SPI1 | chr11:71132725-71133001 | GM12891 | blood: | n/a | n/a |
26 | SPI1 | chr11:71134303-71134592 | GM12891 | blood: | n/a | chr11:71134475-71134484 |
27 | SPI1 | chr11:71134321-71134527 | GM12878 | blood: | n/a | chr11:71134475-71134484 |
28 | SPI1 | chr11:71132873-71133015 | GM12878 | blood: | n/a | n/a |
29 | STAT3 | chr11:71134394-71134504 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | ZEB1 | chr11:71134227-71134469 | GM12878 | blood: | n/a | n/a |
31 | ZNF384 | chr11:71132837-71132898 | GM12878 | blood: | n/a | n/a |
32 | ZNF384 | chr11:71134283-71134735 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:71134417-71134467 | HIPEpiC | eye: | n/a |
2 | chr11:71134417-71134467 | NH-A | brain: | n/a |
3 | chr11:71134417-71134467 | NHDF-neo | bronchial: | n/a |
4 | chr11:71134417-71134467 | GM19239 | blood: | n/a |
5 | chr11:71134417-71134467 | PFSK-1 | brain: | n/a |
6 | chr11:71134417-71134467 | ProgFib | skin: | n/a |
7 | chr11:71134417-71134467 | HL-60 | blood: | n/a |
8 | chr11:71134417-71134467 | HUVEC | blood vessel: | n/a |
9 | chr11:71134417-71134467 | ECC-1 | luminal epithelium: | n/a |
10 | chr11:71134417-71134467 | HRPEpiC | eye: | n/a |
11 | chr11:71134417-71134467 | K562 | blood: | n/a |
12 | chr11:71134417-71134467 | PANC-1 | pancreas: | n/a |
13 | chr11:71134417-71134467 | AG09309 | skin: | n/a |
14 | chr11:71134417-71134467 | NT2-D1 | testis: | n/a |
15 | chr11:71134417-71134467 | LNCaP | prostate: | n/a |
16 | chr11:71134417-71134467 | Caco-2 | colon: | n/a |
17 | chr11:71134417-71134467 | AG09319 | gingival: | n/a |
18 | chr11:71134417-71134467 | GM12878 | blood: | n/a |
19 | chr11:71134417-71134467 | BE2_C | brain: | n/a |
20 | chr11:71134417-71134467 | Jurkat | blood: | n/a |
21 | chr11:71134417-71134467 | SK-N-SH_RA | brain: | n/a |
22 | chr11:71134417-71134467 | AoSMC | blood vessel: | n/a |
23 | chr11:71134417-71134467 | AG04450 | lung: | fetal |
24 | chr11:71134417-71134467 | GM12892 | blood: | n/a |
25 | chr11:71134417-71134467 | SAEC | small airway: | n/a |
26 | chr11:71134417-71134467 | CMK | blood: | n/a |
27 | chr11:71134417-71134467 | T-47D | breast: | n/a |
28 | chr11:71134417-71134467 | H1-hESC | embryonic stem cell: | embryo |
29 | chr11:71134417-71134467 | PrEC | prostate: | n/a |
30 | chr11:71134417-71134467 | HEK293 | kidney: | embryo |
31 | chr11:71134417-71134467 | HCPEpiC | choroid plexus: | n/a |
32 | chr11:71134417-71134467 | HepG2 | liver: | n/a |
33 | chr11:71134417-71134467 | U87 | brain: | n/a |
34 | chr11:71134417-71134467 | MCF-7 | breast: | n/a |
35 | chr11:71134417-71134467 | BJ | skin: | n/a |
36 | chr11:71134417-71134467 | HEEpiC | esophagus: | n/a |
37 | chr11:71134417-71134467 | HNPCEpiC | eye: | n/a |
38 | chr11:71134417-71134467 | HCF | heart: | n/a |
39 | chr11:71134417-71134467 | Hepatocyte | liver: | n/a |
40 | chr11:71134417-71134467 | IMR90 | lung: | fetal |
41 | chr11:71134417-71134467 | AG10803 | skin: | n/a |
42 | chr11:71134417-71134467 | RPTEC | kidney: | n/a |
43 | chr11:71134417-71134467 | HAEpiC | amniotic membrane: | n/a |
44 | chr11:71134417-71134467 | HCT-116 | colon: | n/a |
45 | chr11:71134417-71134467 | ovcar-3 | ovarian: | n/a |
46 | chr11:71134417-71134467 | NHBE | bronchial: | n/a |
47 | chr11:71134417-71134467 | MCF10A-Er-Src | breast: | n/a |
48 | chr11:71134417-71134467 | GM06990 | blood: | n/a |
49 | chr11:71134417-71134467 | SKMC | muscle: | n/a |
50 | chr11:71134417-71134467 | SK-N-SH | brain: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:71131198..71133245-chr11:71150610..71153048,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DHCR7-3 | chr11:71132847-71132950 | NONHSAT022677 |
2 | lnc-DHCR7-3 | chr11:71134380-71134469 | NONHSAT022677 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000172900 | TF binding region |
ENSG00000172900 | CpG island |
ENSG00000172893 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561742354 | chr11:71132833-71132834 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs374789302 | chr11:71132835-71132836 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs12803256 | chr11:71132868-71132869 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs548439431 | chr11:71132921-71132922 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs560203001 | chr11:71132933-71132934 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs7933382 | chr11:71132965-71132966 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs376131057 | chr11:71133028-71133029 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs71049979 | chr11:71133051-71133052 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs71464390 | chr11:71133059-71133060 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs142584030 | chr11:71133067-71133068 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs372263527 | chr11:71133085-71133086 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs371422574 | chr11:71133091-71133092 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs11233608 | chr11:71133093-71133094 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs374690562 | chr11:71133095-71133096 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs374438507 | chr11:71133096-71133097 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs367594860 | chr11:71133098-71133099 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs368993407 | chr11:71133104-71133105 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs113057054 | chr11:71133115-71133116 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs12226865 | chr11:71133121-71133122 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs371738975 | chr11:71133126-71133127 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs12226866 | chr11:71133127-71133128 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs12226867 | chr11:71133129-71133130 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs369284233 | chr11:71133131-71133132 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs185378533 | chr11:71133133-71133134 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs201629616 | chr11:71133154-71133155 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs200113304 | chr11:71133155-71133156 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs201303472 | chr11:71133156-71133157 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs71464391 | chr11:71133158-71133159 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs10898117 | chr11:71133217-71133218 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs1790357 | chr11:71133260-71133261 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs113367264 | chr11:71133263-71133264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550411038 | chr11:71133268-71133269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs74423151 | chr11:71133295-71133296 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190700039 | chr11:71133337-71133338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77800985 | chr11:71133371-71133372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370856680 | chr11:71133377-71133378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144698007 | chr11:71133378-71133379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs374628454 | chr11:71133396-71133397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112310461 | chr11:71133437-71133438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147912234 | chr11:71133473-71133474 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs180764313 | chr11:71133474-71133475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555630428 | chr11:71133516-71133517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs112986116 | chr11:71133530-71133531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576044743 | chr11:71133532-71133533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185429128 | chr11:71133540-71133541 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370012700 | chr11:71133547-71133548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560241621 | chr11:71133591-71133592 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs111504968 | chr11:71133598-71133599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12573862 | chr11:71133599-71133600 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs113666287 | chr11:71133615-71133616 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:71123600-71139600 | Weak transcription | Right Atrium | heart |
2 | chr11:71129200-71133600 | Enhancers | Primary B cells from cord blood | blood |
3 | chr11:71129200-71134000 | Enhancers | GM12878-XiMat | blood |
4 | chr11:71131400-71133000 | Enhancers | Liver | Liver |
5 | chr11:71131800-71133800 | Weak transcription | Primary B cells from peripheral blood | blood |
6 | chr11:71132000-71134000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
7 | chr11:71132200-71133000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
8 | chr11:71132600-71144000 | Weak transcription | Spleen | Spleen |
9 | chr11:71132800-71134000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
10 | chr11:71133600-71134000 | Weak transcription | Primary B cells from cord blood | blood |
11 | chr11:71133800-71135400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
12 | chr11:71133800-71135400 | Enhancers | Primary B cells from peripheral blood | blood |
13 | chr11:71134000-71135000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr11:71134000-71135000 | Flanking Active TSS | GM12878-XiMat | blood |
15 | chr11:71134000-71135200 | Enhancers | Primary B cells from cord blood | blood |
16 | chr11:71134000-71135400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
17 | chr11:71134000-71135400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
18 | chr11:71134000-71135400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
19 | chr11:71134000-71135400 | Enhancers | HMEC | breast |